Charles E. Elson

6.4k total citations
102 papers, 5.1k citations indexed

About

Charles E. Elson is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Charles E. Elson has authored 102 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 21 papers in Surgery and 20 papers in Physiology. Recurrent topics in Charles E. Elson's work include Plant biochemistry and biosynthesis (21 papers), Cholesterol and Lipid Metabolism (19 papers) and Antioxidant Activity and Oxidative Stress (15 papers). Charles E. Elson is often cited by papers focused on Plant biochemistry and biosynthesis (21 papers), Cholesterol and Lipid Metabolism (19 papers) and Antioxidant Activity and Oxidative Stress (15 papers). Charles E. Elson collaborates with scholars based in United States, Jordan and Malaysia. Charles E. Elson's co-authors include Asaf A. Qureshi, Huanbiao Mo, Earl Shrago, W. C. Burger, David M. Peterson, N. Abuirmeileh, Martin A. Tanner, Austin L. Shug, Michael N. Gould and Zafeer Z. Din and has published in prestigious journals such as Science, Journal of Biological Chemistry and American Journal of Clinical Nutrition.

In The Last Decade

Charles E. Elson

101 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles E. Elson United States 41 2.4k 1.0k 834 751 729 102 5.1k
Asaf A. Qureshi United States 39 1.8k 0.8× 1.6k 1.6× 750 0.9× 732 1.0× 341 0.5× 100 4.8k
Atif B. Awad United States 36 1.7k 0.7× 425 0.4× 1.5k 1.8× 550 0.7× 436 0.6× 79 4.3k
Kenneth K. Carroll Canada 30 1.3k 0.6× 641 0.6× 343 0.4× 373 0.5× 532 0.7× 88 3.8k
Tae‐Sook Jeong South Korea 45 3.0k 1.3× 1.4k 1.4× 732 0.9× 1.3k 1.7× 436 0.6× 191 6.6k
Diane F. Birt United States 36 2.3k 1.0× 787 0.8× 378 0.5× 1.1k 1.4× 535 0.7× 144 5.8k
Siegfried Wolffram Germany 40 1.7k 0.7× 1.8k 1.8× 285 0.3× 909 1.2× 331 0.5× 113 5.8k
Michihiro Sugano Japan 49 2.5k 1.1× 746 0.7× 2.3k 2.7× 904 1.2× 311 0.4× 372 8.2k
Huanbiao Mo United States 29 1.4k 0.6× 908 0.9× 511 0.6× 381 0.5× 626 0.9× 64 3.5k
Norbert Latruffe France 44 4.4k 1.8× 659 0.6× 471 0.6× 446 0.6× 882 1.2× 194 7.7k
Ikuo Ikeda Japan 46 1.8k 0.8× 926 0.9× 2.0k 2.4× 262 0.3× 229 0.3× 164 5.9k

Countries citing papers authored by Charles E. Elson

Since Specialization
Citations

This map shows the geographic impact of Charles E. Elson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Elson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Elson more than expected).

Fields of papers citing papers by Charles E. Elson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Elson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Elson. The network helps show where Charles E. Elson may publish in the future.

Co-authorship network of co-authors of Charles E. Elson

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Elson. A scholar is included among the top collaborators of Charles E. Elson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Elson. Charles E. Elson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hentosh, Patricia, et al.. (2001). Sterol‐independent regulation of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase in tumor cells. Molecular Carcinogenesis. 32(3). 154–166. 65 indexed citations
2.
Mo, Huanbiao, et al.. (2000). Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomas. Cancer Letters. 157(2). 145–153. 18 indexed citations
3.
He, Lei, et al.. (1997). Isoprenoids Suppress the Growth of Murine B16 Melanomas In Vitro and In Vivo. Journal of Nutrition. 127(5). 668–674. 233 indexed citations
4.
Elson, Charles E., et al.. (1997). Inhibition of type I and type II geranylgeranyl-protein transferases by the monoterpene perillyl alcohol in NIH3T3 cells. Biochemical Pharmacology. 54(1). 113–120. 56 indexed citations
5.
Qureshi, Asaf A., et al.. (1996). Dietary α-Tocopherol Attenuates the Impact of γ-Tocotrienol on Hepatic 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity in Chickens. Journal of Nutrition. 126(2). 389–394. 133 indexed citations
6.
Hildebrandt, Leslie Anne, et al.. (1996). Acyl CoA and Lipid Synthesis from Ketone Bodies by the Extramitochondrial Fraction of Hepatoma Tissue. Biochemical and Biophysical Research Communications. 225(1). 307–312. 6 indexed citations
7.
Elson, Charles E.. (1996). Novel Lipids and Cancer. Advances in experimental medicine and biology. 399. 71–86. 17 indexed citations
8.
Hildebrandt, Leslie Anne, et al.. (1995). Geraniol, an Inhibitor of Mevalonate Biosynthesis, Suppresses the Growth of Hepatomas and Melanomas Transplanted to Rats and Mice. Journal of Nutrition. 125(11). 2763–2767. 87 indexed citations
9.
Elson, Charles E. & Asaf A. Qureshi. (1995). Coupling the cholesterol- and tumor-suppressive actions of palm oil to the impact of its minor constituents on 3-hydroxy-3-methylglutaryl coenzyme a reductase activity. Prostaglandins Leukotrienes and Essential Fatty Acids. 52(2-3). 205–208. 51 indexed citations
10.
Elson, Charles E.. (1995). Suppression of Mevalonate Pathway Activities by Dietary Isoprenoids: Protective Roles in Cancer and Cardiovascular Disease. Journal of Nutrition. 125(6 Suppl). 1666S–1672S. 107 indexed citations
11.
Elson, Charles E., et al.. (1994). The Chemoprevention of Cancer by Mevalonate-Derived Constituents of Fruits and Vegetables. Journal of Nutrition. 124(5). 607–614. 103 indexed citations
12.
Elegbede, J. Abiodun, Terese H. Maltzman, Charles E. Elson, & Michael N. Gould. (1993). Effects of anticarcinogenic monoterpenes on phase II hepatic metabolizing enzymes. Carcinogenesis. 14(6). 1221–1223. 70 indexed citations
13.
Elson, Charles E. & Roslyn B. Alfin‐Slater. (1992). Tropical oils: Nutritional and scientific issues. Critical Reviews in Food Science and Nutrition. 31(1-2). 79–102. 86 indexed citations
14.
Peterson, D. M., et al.. (1989). Stimulation of avian cholesterol metabolism by alpha-tocopherol. Nutrition reports international. 40(5). 993–1001. 16 indexed citations
15.
Maltzman, Terese H., et al.. (1989). The prevention of nitrosomethylurea-induced mammary tumors by d-limonene and orange oil. Carcinogenesis. 10(4). 781–783. 111 indexed citations
16.
Russin, William A., et al.. (1989). Inhibition of rat mammary carcinogenesis by monoterpenoids. Carcinogenesis. 10(11). 2161–2164. 70 indexed citations
17.
Elson, Charles E., et al.. (1988). Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis. Carcinogenesis. 9(2). 331–332. 131 indexed citations
18.
Kim, Jung Hee, Earl Shrago, & Charles E. Elson. (1988). Age-related changes in respiration coupled to phosphorylation. II. cardiac mitochondria. Mechanisms of Ageing and Development. 46(1-3). 279–290. 49 indexed citations
19.
Qureshi, Asaf A., et al.. (1988). Inhibition of hepatic mevalonate biosynthesis by the monoterpene, d-limonene. Journal of Agricultural and Food Chemistry. 36(6). 1220–1224. 47 indexed citations
20.
Pariza, Michael W., Walter A. Hargraves, Maro Christou, et al.. (1986). Modulation of carcinogenesis by dietary factors. Environmental Health Perspectives. 67. 25–29. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026